BTT-30639-07742
3 vaccinations
5 coded responses
40 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 540 / WI
- Registered
- 2021-03-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-23
Registered in v-safe
-
2021-03-23
Dose 1 — Moderna
- 2021-03-23
- 2021-03-24
- 2021-03-25
-
2021-03-26
Survey response — days 1–6 daily, dose 1MedDRA: Palpitations — Feeling: GoodFree text: Unexpected heart palpitations at onset of moderate exerciseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-28
-
2021-03-29
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-03-30
-
2021-04-06
Survey response — day 14, dose 1MedDRA: Rash — Feeling: GoodFree text: A rash appeared on the arm that received the injection and persisted for four days.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-13
-
2021-04-20
Dose 2 — Moderna
- 2021-04-20
-
2021-04-21
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-04-22
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2021-04-23
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Itching · HeadacheAdult check-in
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-05-04
- 2021-05-11
- 2021-05-18
- 2021-05-25
- 2021-06-01
-
2021-07-20
Survey response — 3 months, dose 2MedDRA: Cough, Nasopharyngitis, Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test negative, Sinus congestion, Upper-airway cough syndrome — Feeling: Fair · Be unable to work or attend schoolFree text: Cold symptoms following exposure to unvaccinated children: sore throat, followed by sinus congestion and runny nose. No fever, coughing only due to post-nasal drip. Negative COVID-19 test.MedDRA releases: 2024-11 · check-in free text available
- 2021-10-19
-
2021-12-02
Dose 3 — Moderna
-
2021-12-02
Health check-in — day 0, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-12-03
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-12-04
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Swelling · Muscle or body achesAdult check-in
-
2021-12-05
Survey response — days 1–6 daily, dose 3MedDRA: Migraine with aura — Feeling: Good · Site: Pain, Swelling · Muscle or body achesFree text: Experienced migraine aura (no headache) for 20-30 minute durationMedDRA releases: 2024-11 · check-in free text available
- 2021-12-06
- 2021-12-07
- 2021-12-08
- 2021-12-09
- 2021-12-16
- 2021-12-23
- 2021-12-30
- 2022-01-06
- 2022-01-13
-
2022-03-03
Survey response — 3 months, dose 3MedDRA: Rash, Skin disorder, Urticaria — Feeling: GoodFree text: Undiagnosed skin condition, rash or hives, unknown if related to vaccine booster.MedDRA releases: 2024-11 · check-in free text available
- 2022-06-04
- 2022-12-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-23 | Moderna | |
| 2 | 2021-04-20 | Moderna | |
| 3 | 2021-12-02 | Moderna | No |
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Unexpected heart palpitations at onset of moderate exercise
Release 7 — day 14, dose 1
Symptoms: A rash appeared on the arm that received the injection and persisted for four days.
Release 9 — 3 months, dose 2
Symptoms: Cold symptoms following exposure to unvaccinated children: sore throat, followed by sinus congestion and runny nose. No fever, coughing only due to post-nasal drip. Negative COVID-19 test.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Experienced migraine aura (no headache) for 20-30 minute duration
Release 11 — 3 months, dose 3
Symptoms: Undiagnosed skin condition, rash or hives, unknown if related to vaccine booster.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Sinus congestion | · | · | ✓ |
| SD | Skin disorder | · | · | ✓ |
| SD | Upper-airway cough syndrome | · | · | ✓ |
| SD | Urticaria | · | · | ✓ |
| SRO | Migraine with aura | · | · | ✓ |
| SRO | Palpitations | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release